Cube Labs SpA

Cube Labs SpA EBITDA per Employee

The EBITDA per Employee of Cube Labs SpA (CUBE.MI) as of Oct 27, 2026 is 119,174.00 EUR. In the previous year, EBITDA per Employee was -234,520.00 EUR — a change of -150.82% (higher).

EBITDA per Employee

119,174.00EUR

YoY

-150.82%

Last updated:

EBITDA per Employee of Cube Labs SpA is 2025 119,174.00 EUR. EBITDA per Employee of Cube Labs SpA was 2024 -234,520.00 EUR. It decreases by -150.82% higher compared to the previous year.

The Cube Labs SpA EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2020
167,705.00 EUR
Jan 1, 2021
205,795.00 EUR
Jan 1, 2022
26,810.00 EUR
Jan 1, 2023
-211,625.00 EUR
Jan 1, 2024
-234,520.00 EUR
Jan 1, 2025
119,174.00 EUR
The Cube Labs SpA EBITDA per Employee history
YEAREBITDA per EmployeeYoY
119,174.00EUR-150.82%
-234,520.00EUR+10.82%
-211,625.00EUR-889.35%
26,810.00EUR-86.97%
205,795.00EUR+22.71%
167,705.00EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cube Labs SpA Stock analysis

What does Cube Labs SpA do? Cube Labs SpA generates revenue through healthcare technology services, focusing on creating and supporting companies from the R&D stage. The firm provides entrepreneurial and operational support for healthcare management and technology solutions, targeting global markets. It promotes and implements scientific research results in human health, biotechnology, and nanotechnology, serving clients seeking innovative healthcare technology integration. The company operates with a lean team of two full-time employees, leveraging its expertise in translating research into practical applications. Cube Labs SpA's business model centers on bridging the gap between scientific research and market-ready healthcare technology. By offering tailored support for startups in the healthcare sector, the company helps clients navigate the complexities of R&D commercialization. Its global operations allow it to serve clients across different regions, capitalizing on the increasing demand for advanced healthcare solutions. The firm's revenue streams are derived from its specialized services in healthcare technology development and implementation. The company's primary clients are healthcare technology startups and established firms looking to integrate scientific research into their operations. Cube Labs SpA supports these clients through its expertise in biotechnology and nanotechnology applications, delivering customized solutions that address specific market needs. With a focus on operational support and entrepreneurial guidance, the firm helps clients accelerate their time-to-market for innovative healthcare products. Cube Labs SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cube Labs SpA stock

EBITDA per Employee of Cube Labs SpA is 119,174.00 EUR in 2025.

EBITDA per Employee of Cube Labs SpA changed from -234,520.00 EUR to 119,174.00 EUR, representing a -150.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Cube Labs SpA since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Cube Labs SpA historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Cube Labs SpA

All Key Metrics — Cube Labs SpA